Complications during extracorporeal membrane oxygenation: why collaboration is key.
作者信息
Bembea Melania M
机构信息
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, MD.
出版信息
Pediatr Crit Care Med. 2015 Feb;16(2):193-5. doi: 10.1097/PCC.0000000000000328.
Abstract
摘要
相似文献
1
Complications during extracorporeal membrane oxygenation: why collaboration is key.体外膜肺氧合期间的并发症：协作为何至关重要。
Pediatr Crit Care Med. 2015 Feb;16(2):193-5. doi: 10.1097/PCC.0000000000000328.
2
Low-dose heparin during extracorporeal membrane oxygenation treatment in adults.成人体外膜肺氧合治疗期间的低剂量肝素。
Intensive Care Med. 2015 Nov;41(11):2020-1. doi: 10.1007/s00134-015-4015-7. Epub 2015 Aug 14.
3
Activated recombinant factor VII and extracorporeal membrane oxygenation: everything is all right, nothing is wrong?活化重组凝血因子VII与体外膜肺氧合：一切正常，没有问题？
Pediatr Crit Care Med. 2010 Jan;11(1):155-6. doi: 10.1097/PCC.0b013e3181b80dc1.
4
Laboratory and clinical predictors of thrombosis and hemorrhage in 29 pediatric extracorporeal membrane oxygenation nonsurvivors.29例小儿体外膜肺氧合治疗死亡病例中血栓形成和出血的实验室及临床预测因素
Pediatr Dev Pathol. 2010 Sep-Oct;13(5):385-92. doi: 10.2350/09-09-0704-OA.1. Epub 2010 Jan 19.
5
Bleeding and Thrombotic Complications in the Use of Extracorporeal Membrane Oxygenation.体外膜肺氧合使用中的出血和血栓并发症。
Semin Thromb Hemost. 2018 Feb;44(1):20-29. doi: 10.1055/s-0037-1606179. Epub 2017 Sep 12.
6
Extracorporeal membrane oxygenation-hemostatic complications.体外膜肺氧合-止血并发症
Transfus Med Rev. 2015 Apr;29(2):90-101. doi: 10.1016/j.tmrv.2014.12.001. Epub 2014 Dec 18.
7
Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.体外膜肺氧合中凝血和纤维蛋白溶解激活标志物的年龄差异。
Pediatr Crit Care Med. 2014 Jun;15(5):e198-205. doi: 10.1097/PCC.0000000000000107.
8
Clinical management of the extracorporeal membrane oxygenation circuit.体外膜肺氧合回路的临床管理。
Pediatr Crit Care Med. 2013 Jun;14(5 Suppl 1):S13-9. doi: 10.1097/PCC.0b013e318292ddc8.
9
Heart and ECMO: are we ready?心脏与体外膜肺氧合：我们准备好了吗？
Ann Card Anaesth. 2011 May-Aug;14(2):161-2. doi: 10.4103/0971-9784.81578.
10
Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.体外膜肺氧合期间难治性出血时的激活重组因子 VII。
Pediatr Crit Care Med. 2010 Jan;11(1):98-102. doi: 10.1097/PCC.0b013e3181b0620b.
引用本文的文献
1
Overt Disseminated Intravascular Coagulation with Severe Hypofibrinogenemia During Veno-Venous Extracorporeal Membrane Oxygenation.体外膜肺氧合期间伴严重低纤维蛋白原血症的显性弥漫性血管内凝血。
J Extra Corpor Technol. 2022 Jun;54(2):148-152. doi: 10.1182/ject-148-152.
2
Assessing Anticoagulation in Neonates With Congenital Diaphragmatic Hernia During Extracorporeal Membrane Oxygenation: Does Anti-Factor Xa or Thromboelastometry Provide Additional Benefit?评估先天性膈疝新生儿体外膜肺氧合期间的抗凝治疗：抗Xa因子检测或血栓弹力图检测是否能带来额外益处？
Front Pediatr. 2021 Sep 17;9:685906. doi: 10.3389/fped.2021.685906. eCollection 2021.
本文引用的文献
1
Association of bleeding and thrombosis with outcome in extracorporeal life support.体外生命支持中出血和血栓形成与预后的关联
Pediatr Crit Care Med. 2015 Feb;16(2):167-74. doi: 10.1097/PCC.0000000000000317.
2
Impact of fluid balance on outcome of adult patients treated with extracorporeal membrane oxygenation.液体平衡对接受体外膜肺氧合治疗的成年患者预后的影响。
Intensive Care Med. 2014 Sep;40(9):1256-66. doi: 10.1007/s00134-014-3360-2. Epub 2014 Jun 17.
3
Venovenous extracorporeal life support improves survival in adult trauma patients with acute hypoxemic respiratory failure: a multicenter retrospective cohort study.静脉-静脉体外生命支持可提高急性低氧性呼吸衰竭成人创伤患者的生存率：一项多中心回顾性队列研究。
J Trauma Acute Care Surg. 2014 May;76(5):1275-81. doi: 10.1097/TA.0000000000000213.
4
Safety and efficacy of recombinant activated factor VII for refractory hemorrhage in pediatric patients on extracorporeal membrane oxygenation: a single center review.重组活化凝血因子 VII 用于体外膜肺氧合支持下儿科难治性出血的安全性与有效性：单中心回顾分析
Perfusion. 2014 Mar;29(2):163-70. doi: 10.1177/0267659113499782. Epub 2013 Aug 13.
5
Extracorporeal Life Support Organization Registry Report 2012.体外生命支持组织登记报告 2012.
ASAIO J. 2013 May-Jun;59(3):202-10. doi: 10.1097/MAT.0b013e3182904a52.
6
Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey.体外膜肺氧合患者抗凝管理的变异性：一项国际调查。
Pediatr Crit Care Med. 2013 Feb;14(2):e77-84. doi: 10.1097/PCC.0b013e31827127e4.
7
Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) severe respiratory failure in Japan.日本应用体外膜肺氧合治疗 2009 年甲型 H1N1 流感所致严重呼吸衰竭
J Anesth. 2012 Oct;26(5):650-7. doi: 10.1007/s00540-012-1402-x. Epub 2012 May 23.
8
Hemostasis in neonates and children: pitfalls and dilemmas.新生儿和儿童的止血：陷阱和困境。
Blood Rev. 2010 Mar;24(2):63-8. doi: 10.1016/j.blre.2009.12.001. Epub 2010 Jan 13.
9
Intravascular volume administration: a contributing risk factor for intracranial hemorrhage during extracorporeal membrane oxygenation?血管内容量管理：体外膜肺氧合期间颅内出血的一个促成风险因素？
Pediatrics. 2008 Jun;121(6):e1599-603. doi: 10.1542/peds.2007-2380. Epub 2008 May 5.
10
The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview.国际血栓与止血协会弥散性血管内凝血科学标准化委员会评分系统：五年综述
J Thromb Haemost. 2007 Mar;5(3):604-6. doi: 10.1111/j.1538-7836.2007.02313.x. Epub 2006 Nov 10.
Zotero 插件